Elanco Animal Health makes pet health and farm animal products that prevent and treat disease in animals. ELAN reports earnings on Fri, Nov 6, 2026. Analyst consensus is Strong Buy, based on the latest ratings from 4 firms (3 buy, 1 hold, 0 sell). In the past 30 days there were 1 dark pool print.
Prices, price targets and earnings estimates for ELAN are shown to AI Starter and AI Pro members. Ratings, flow and news are open to everyone.See plansSign in
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ELAN is in one of them and how their past ELAN trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Elanco Animal Health
Elanco Animal Health is based in Indianapolis, Indiana, and develops and sells products to prevent and treat disease in animals. Its pet health products include flea and tick treatments and prescription medicines. It also sells farm animal products, including antibiotics and other treatments used in livestock and poultry production. Its customers include veterinarians, retailers, distributors and farm animal producers.
